Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia

NCT04477954 is registered in ClinicalTrials.gov with Asociación Argentina de Medicina Hiperbárica e Investigación as lead sponsor.

NCT NCT04477954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia
Lead sponsor
Asociación Argentina de Medicina Hiperbárica e Investigación
Phase
Phase 2
Overall status
Terminated
Start date
July 6, 2020
Completion date
December 30, 2020
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19